"EvergreenHealth Multiple Sclerosis Services provides services in Kirkland, WA. We offer a state-of-the-art facility with patient-friendly access, an on-site clinical research lab, and comprehensive rehabilitation services."

During the past decade, MS Center at Evergreen Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MS Center at Evergreen Health" #1 collaborator was "Biogen" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MS Center at Evergreen Health" are "Multiple Sclerosis" (3 trials). Many other conditions were trialed in "MS Center at Evergreen Health" in a lesser frequency.

Most popular intervention types in "MS Center at Evergreen Health" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anesthetic Topical Adhesive Synera" (1 trials). Other intervention names were less common.

The vast majority of trials in "MS Center at Evergreen Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MS Center at Evergreen Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MS Center at Evergreen Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MS Center at Evergreen Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".